ArticlePDF AvailableLiterature Review

Abstract and Figures

For patients who present with an out-of-hospital refractory cardiac arrest, in-hospital extracorporeal life-support (ECLS) initiation represents an alternative therapy which allows significant survival. We describe here the first case of out-of-hospital ECLS implantation in a patient presenting with a refractory cardiac arrest during a road race. ECLS was initiated within the MICU ambulance 60 min after cardiac arrest and enabled restoration of cardiac output to 4.5 l min⁻¹. Coronarography revealed a severe isolated stenosis of the right coronary artery, which was treated by angioplasty. The cardiogenic shock resolved progressively, enabling ECLS weaning within 48h, while renal, hepatic, and respiratory functions recovered simultaneously.
Content may be subject to copyright.
Resuscitation
82 (2011) 1239–
1242
Contents
lists
available
at
ScienceDirect
Resuscitation
jo
u
rn
al
hom
epage
:
www.elsevier.com/locate/resuscitation
Case
report
Out-of-hospital
extra-corporeal
life
support
implantation
during
refractory
cardiac
arrest
in
a
half-marathon
runner
Guillaume
Lebretona,
Matteo
Pozzia,
Charles-Edouard
Luytb,
Jean
Chastreb,
Pierre
Carlic,
Alain
Paviea,
Pascal
Leprincea,
Benoît
Vivienc,
aService
de
Chirurgie
Cardio-Thoracique,
Hôpital
Pitié-Salpêtrière,
Université
Pierre
et
Marie
Curie
Paris
6,
Paris,
France
bService
de
Réanimation
Médicale,
Hôpital
Pitié-Salpêtrière,
Université
Pierre
et
Marie
Curie
Paris
6,
Paris,
France
cSAMU
de
Paris,
Département
d’Anesthésie
Réanimation,
Hôpital
Necker
Enfants
Malades,
Université
Paris
Descartes
Paris
5,
Paris,
France
a
r
t
i
c
l
e
i
n
f
o
Article
history:
Received
9
January
2011
Received
in
revised
form
3
March
2011
Accepted
2
April
2011
Keywords:
Sport
sudden
death
Refractory
cardiac
arrest
Cardiopulmonary
resuscitation
Out-of-hospital
ECLS
a
b
s
t
r
a
c
t
For
patients
who
present
with
an
out-of-hospital
refractory
cardiac
arrest,
in-hospital
extracorporeal
life-
support
(ECLS)
initiation
represents
an
alternative
therapy
which
allows
significant
survival.
We
describe
here
the
first
case
of
out-of-hospital
ECLS
implantation
in
a
patient
presenting
with
a
refractory
cardiac
arrest
during
a
road
race.
ECLS
was
initiated
within
the
MICU
ambulance
60
min
after
cardiac
arrest
and
enabled
restoration
of
cardiac
output
to
4.5
l
min1.
Coronarography
revealed
a
severe
isolated
stenosis
of
the
right
coronary
artery,
which
was
treated
by
angioplasty.
The
cardiogenic
shock
resolved
pro-
gressively,
enabling
ECLS
weaning
within
48
h,
while
renal,
hepatic,
and
respiratory
functions
recovered
simultaneously.
© 2011 Elsevier Ireland Ltd. All rights reserved.
1.
Introduction
Risk
of
sudden
cardiac
death
associated
with
road
races
among
athletes
>35
years
of
age
ranges
from
1/15,000
to
1/22,0000.1–3
Whereas
pre-participation
cardiovascular
evaluation
of
competi-
tive
athletes
has
been
shown
to
be
effective
for
the
detection
of
potentially
lethal
cardiomyopathy,
decrease
in
mortality
recently
observed
among
participants
experiencing
cardiac
arrest
during
road
races
is
largely
attributable
to
wider
access
to
defibrillators
now
available
on
many
courses.1,4,5 Elsewhere,
for
cardiac
arrest
patients
who
do
not
respond
to
conventional
cardiopulmonary
resuscitation
(CPR),
extracorporeal
life-support
(ECLS)
may
rep-
resent
an
alternative
therapeutic
approach
allowing
significant
survival
rates.6However,
ECLS
is
not
available
in
every
hospital,
and
time
required
to
transfer
the
patient
from
the
race
to
the
car-
diothoracic
department
may
be
long,
worsening
prognosis.6–7 To
the
best
of
our
knowledge,
we
describe
here
the
first
case
of
out-of-
hospital
ECLS
implantation
in
a
patient
presenting
with
refractory
cardiac
arrest
during
a
road
race.
A
Spanish
translated
version
of
the
abstract
of
this
article
appears
as
Appendix
in
the
final
online
version
at
doi:10.1016/j.resuscitation.2011.04.002.
Corresponding
author
at:
SAMU
de
Paris,
Département
d’Anesthésie-
Réanimation,
Hôpital
Necker
Enfants
Malades,
149
Rue
de
Sèvres,
75730
Paris
Cedex
15,
France.
Tel.:
+33
1
44
49
24
72;
fax:
+33
1
44
49
23
25.
E-mail
address:
benoit.vivien@nck.aphp.fr
(B.
Vivien).
2.
Case
A
48
year-old
runner
collapsed
near
the
end
of
the
Paris
half-marathon.
The
patient
was
immediately
taken
care
of
by
pro-
fessional
rescuers
who
performed
BLS
with
no-flow
<1
min.
Five
minutes
later,
the
Mobile
Intensive
Care
Unit
(MICU)
prehospi-
tal
medical
team
found
the
patient
in
asystolic
cardiac
arrest.
After
30
min
ACLS
with
continuous
chest
compressions,
ventila-
tion,
5
times
1
mg
intravenous
epinephrine
administration,
the
patient
was
still
in
refractory
cardiac
arrest
but
presented
signs
of
life,
i.e.
spontaneous
inspiratory
movements,
bilateral
pupil-
lary
light
reflexes,
and
endtidal
CO2about
30
mmHg.
Therapeutic
mild
hypothermia
was
induced
by
infusion
of
1500
ml
of
cold
physiological
saline
(+4 C),
and
moreover
facilitated
by
the
low
outside
temperature
(about
+2 C).
Therefore
the
medical
team
decided
to
set
up
an
ECLS
on
the
out-of-hospital
theater.
While
continuing
CPR
(Fig.
1),
direct
surgical
access
to
right
femoral
ves-
sels
for
veno-arterial
ECLS
implantation
(Revolution
Centrifugal
Blood
Pump,
Sorin
Group
Italia
S.r.l.TM,
Milano,
Italy;
Cannulae
Edwards
FemTrack
18F–28F;
Edwards
LifesciencesTM,
Irvine,
CA)
was
performed
within
the
MICU
ambulance
(Fig.
2).
The
femoral
vein
appeared
collapsed
because
of
severe
hypovolemia,
which
made
cannulation
difficult,
and
therefore
fluid
loading
was
con-
tinued
with
2000
ml
of
physiological
serum.
ECLS
was
initiated
at
the
60th
minute
after
cardiac
arrest
(Fig.
3),
and
enabled
restora-
tion
of
a
cardiac
output
of
4.5
l
min1.
Subsequently,
return
of
spontaneous
electrical
cardiac
activity
and
circulation
occurred
0300-9572/$
see
front
matter ©
2011 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.resuscitation.2011.04.002
1240 G.
Lebreton
et
al.
/
Resuscitation
82 (2011) 1239–
1242
Fig.
1.
Direct
surgical
access
to
right
femoral
vessels
for
veno-arterial
cannulation
performed
by
cardiothoracic
surgeons
within
the
MICU
ambulance.
Cardiopul-
monary
resuscitation
was
continued
by
EMS
providers
during
cannulation.
10
min
later.
Laboratory
tests
performed
on
a
venous
blood
sam-
ple
revealed
lactate
concentration
8.1
mmol
l1,
pH
7.08,
HCO3
14.3
mmol
l1,
PaO271
mmHg,
and
PaCO248
mmHg.
Central
tem-
perature
was
31.9 C
on
hospital
admission.
The
patient
was
transferred
to
the
cardiac
catheterization
laboratory.
Coronarogra-
phy
revealed
a
severe
isolated
stenosis
of
the
right
coronary
artery,
which
was
treated
by
angioplasty
(Fig.
4).
Left
ventricular
ejec-
tion
fraction
was
<20%
with
severe
global
hypokinesia,
requiring
continuation
of
ECLS
during
48
h.
The
patient
was
admitted
into
an
ICU
and
sedated
for
36
h,
and
mild
therapeutic
hypothermia
(32–34 C)
was
continued
for
24
h.
The
cardiogenic
shock
progres-
sively
resolved,
enabling
uneventful
ECLS
weaning,
and
myocardial
function
completely
recovered
within
the
next
5
days.
Contem-
poraneously,
renal,
hepatic
and
respiratory
functions
recovered,
parallely
with
normalization
of
biological
parameters.
However,
the
patient
presented
in
a
persistant
vegetative
state
(Glasgow
Outcome
Scale
=
4).
Neurophysiological
investigations
confirmed
the
severe
post-anoxic
encephalopathy.
According
to
the
patient’s
next-of-kin
wishes,
limitation
of
care
was
decided,
and
the
patient
died
on
day
18.
Fig.
2.
Figure
is
showing
the
centrifugal
pump
system
with
the
oxygenator,
and
the
venous
and
arterial
lines,
respectively
connected
to
venous
and
arterial
femoral
cannulae.
Fig.
3.
Patient
under
extra-corporeal
life
support
(ECLS)
within
the
MICU
ambu-
lance.
Picture
was
taken
a
few
minutes
after
end
of
veno-arterial
femoral
cannulation
and
ECLS
initiation.
3.
Discussion
In
a
recent
meta-analysis
on
ECLS
for
cardiac
arrest,
Cardarelli
et
al.
reported
an
overall
survival
to
hospital
discharge
of
40%,
with
a
negative
trend
in
survival
when
manual
CPR
lasted
>30
min
with-
out
prompt
ECLS
initiation
(OR
1.9;
CI95%
0.9–4.2).6These
authors
also
concluded
in
their
analysis
that
neurological
outcome
was
poorly
described
in
the
reviewed
literature.
Duration
of
low-flow
before
ECLS
initiation
is
classically
considered
as
a
major
endpoint
Fig.
4.
Severe
isolated
distal
stenosis
of
the
right
coronary
artery
(arrow)
revealed
on
the
coronarography
performed
immediately
after
hospital
admission.
Since
this
stenosis
was
the
only
finding
revealed
by
coronarography,
an
ischemia
while
the
patient
was
running
had
been
probably
responsible
for
his
cardiac
arrest.
G.
Lebreton
et
al.
/
Resuscitation
82 (2011) 1239–
1242 1241
Fig.
5.
MICU
ambulance
pre-equipped
with
a
ready-to-use
ECLS
device
(Sorin
Cen-
trifugal
Pump®,
Sorin
Group
USA,
Inc.).
Since
2009,
the
cardiothoracic
and
medical
team
are
systematically
present
along
the
race
with
this
pre-equipped
ambulance
for
all
half-marathon
and
full
marathon’s
in
Paris.
(1)
Centrifugal
pump
system,
with
oxygenator
and
command
control
panel;
(2)
diathermic
knife;
(3)
pre-filled
venous
line;
(4)
prefilled
arterial
line.
for
both
survival
and
neurologic
outcome.6–8 Conversely,
a
recent
published
study
focused
on
the
major
importance
of
the
no
flow
duration
before
initiation
of
cardiopulmonary
resuscitation:
among
51
out-of-hospital
cardiac
arrest
patients,
the
2
surviving
patients
presented
no
flows
of
1
min
and
0
min,
and
respectively
low
flows
of
132
min
and
170
min.9
As
we
had
previously
observed
several
refractory
cardiac
arrests
during
road
races
in
Paris
with
prolonged
but
unshortenable
times
for
transfer
to
hospital,
we
have
decided
since
2009
to
upgrade
the
medical
team
for
the
Paris’
half-marathon
and
marathon
races:
both
emergency
physicians
and
cardiothoracic
surgeons
are
sys-
tematically
present
along
the
race,
within
a
MICU
ambulance
pre-equipped
with
a
ready-to-use
pre-primed
ECLS
device
(Fig.
5).
Indeed,
recommendations
on
how
to
improve
survival
for
cardiac
arrest
patients
undergoing
ECLS
focus
on
shortening
ECLS
deploy-
ment
time.6,8
ECLS
was
started
60
min
after
the
cardiac
arrest
in
our
patient.
This
time
is
a
little
longer
than
those
reported
by
Cardarelli
et
al.
(40
[1–180]min),
Chen
et
al.
in
2003
(47.6
±
13.4
min)
and
in
2008
(52.8
±
37.2
min),
Sung
et
al.
(48.5
±
29.0
min),
and
Sin
et
al.
(42.1
±
25.7
min),
but
lower
than
those
reported
by
Kurose
et
al.
(73
±
26
min),
Massetti
et
al.
(105
±
44
min),
Mégarbane
et
al.
(120
[60–180]min)
and
Le
Guen
et
al.
(120
[102–149]min),
all
for
in-hospital
ECLS
implantation.6,9–16 Moreover,
all
those
reports
included
only
in-hospital
cardiac
arrests,
excepted
those
of
Mas-
setti,
Mégarbane
and
Le
Guen,
which
represent
the
longest
times.
Therefore,
our
time
of
60
min
CPR
before
out-of-hospital
ECLS
ini-
tiation
should
be
considered
as
reasonable,
and
nevertheless
is
dramatically
faster
than
the
time
that
would
have
been
necessary
for
an
in-hospital
ECLS
implantation.
For
comparison,
since
time
from
cardiac
arrest
to
in-hospital
ECLS
initiation
had
been
110
min
in
a
2009
Paris’
half-marathon
runner,
that
has
been
the
target
for
our
decision
to
upgrade
our
medical
team
for
major
road
races
in
Paris.
In
our
patient,
return
of
spontaneous
circulation
occurred
10
min
after
ECLS
initiation;
organ
functions
and
excepted
neu-
rological
status
recovered
in
48
h,
enabling
ECLS
weaning.
This
was
most
likely
due
to
the
short
no-flow
time.6,11 Although,
our
patient
did
present
with
severe
post-anoxic
encephalopathy.
These
findings
are
consistent
with
experimental
evidence
that
cerebral
neurons
are
more
vulnerable
than
cardiac
myocytes
to
ischemia.17,18 The
major
neurological
deficit
of
our
patient
is
prob-
ably
linked
to
unefficient
chest
compressions
performed
on
an
ischaemic
stone
heart
worsened
by
a
dehydration-related
hypo-
volemia,
as
suggested
by
the
collapsed
femoral
vein
aspect
during
cannulation.
Cerebral
autoregulation
is
lost
during
prolonged
CPR,
and
cerebral
blood
flow
become
directly
dependant
on
cerebral
perfusion
pressure.10 Considering
that
our
patient
presented
a
car-
diac
arrest
near
the
end
of
the
race,
we
should
have
suspected
hypovolemia,
and
consequently
earlier
initiated
fluid
loading.
The
cardiac
arrest
of
our
patient
occurred
near
the
end
of
the
race,
which
is
in
agreement
with
Redelmeier
who
reported
that
the
most
common
course
location
for
cardiac
arrest
is
close
to
the
finish
line.2Consequently,
we
have
decided
going
forward,
for
Paris’
races,
to
locate
the
ECLS-equipped
MICU
ambulance,
obviously
fully
mobile,
preferentially
along
the
end
of
the
race,
which
could
help
to
furthermore
decrease
time
for
ECLS
initiation
in
a
cardiac
arrest
runner.
At
last,
this
case
was
scheduled
for
a
special
sport
event,
i.d.
a
road
race
in
Paris,
during
which
a
sudden
death
is
expected.
Whereas
emergency
in-hospital
ECLS
implantation
is
not
yet
avail-
able
in
most
of
hospitals
(only
in
4
cardiothoracic
departments
and
1
specialized
ICU
in
Paris),
generalization
of
out-of-hospital
ECLS
implantation
may
be
difficult.
On
the
other
hand,
we
have
in
Paris
an
ECLS
team
(“Unité
Mobile
d’Assistance
Circulatoire,
UMAC”)
which
goes
in
other
hospital
in
Paris
and
suburbs
to
implant
ECLS
for
cardiac
failure
and
in-hospital
cardiac
arrest
patients
with
good
prognostic
factors
(limited
no
flow
<5
min).20 Therefore
we
do
think
that
it
would
be
perfectly
possible
to
have
an
ECLS
team
on
duty
for
out-of-hospital
ECLS
implantation.
The
limitation
factors
are
obviously
the
availability
of
the
team,
and
the
requirement
of
a
specified
pre-equipped
MICU.
Nevertheless,
the
patient
should
be
highly
selected
(no
flow
<5
min
and/or
protective
factors
such
as
hypothermia)
and
the
time
required
until
start
of
ECLS
should
be
significantly
shorter
than
the
expected
time
for
transportation
of
the
patient
to
the
cardiothoracic
department.
4.
Conclusion
Finally,
whereas
many
publications
report
successful
trans-
portation
of
patients
under
ECLS
after
out-of-cardiothoracic
department
but
in-hospital
implantation,19 to
the
best
of
our
knowledge,
our
case
is
the
first
one
attesting
to
the
feasibility
of
complete
out-of-hospital
ECLS
implantation
for
refractory
cardiac
arrest.
Despite
the
patient’s
death,
the
positive
results
for
organs
perfusion
and
recovery
encourage
us
to
continue
this
experiment.
Conflict
of
interest
statement
Authors
have
no
conflict
of
interest.
Funding
None.
Consent
for
publication
Consent
for
publication
of
this
case
report
was
obtained
from
the
next
of
kin
(the
wife)
of
the
patient
presented
in
the
manuscript.
References
1.
Roberts
WO,
Maron
BJ.
Evidence
for
decreasing
occurrence
of
sudden
cardiac
death
associated
with
the
marathon.
J
Am
Coll
Cardiol
2005;46:1373–4.
2.
Redelmeier
DA,
Greenwald
JA.
Competing
risks
of
mortality
with
marathons:
retrospective
analysis.
BMJ
2007;335:1275–7.
3. Tunstall
Pedoe
DS.
Marathon
cardiac
deaths:
the
London
experience.
Sports
Med
2007;37:448–50.
1242 G.
Lebreton
et
al.
/
Resuscitation
82 (2011) 1239–
1242
4.
Ratliff
NB,
Harris
KM,
Smith
SA,
Tankh-Johnson
M,
Gornick
CC,
Maron
BJ.
Cardiac
arrest
in
a
young
marathon
runner.
Lancet
2002;360:542.
5.
Corrado
D,
Basso
C,
Schiavon
M,
Pelliccia
A,
Thiene
G.
Pre-participation
screening
of
young
competitive
athletes
for
prevention
of
sudden
cardiac
death.
J
Am
Coll
Cardiol
2008;52:1981–9.
6.
Cardarelli
MG,
Young
AJ,
Griffith
B.
Use
of
extracorporeal
membrane
oxygena-
tion
for
adults
in
cardiac
arrest
(E-CPR):
a
meta-analysis
of
observational
studies.
ASAIO
J
2009;55:581–6.
7.
Vukmir
RB.
Survival
from
prehospital
cardiac
arrest
is
critically
dependent
upon
response
time.
Resuscitation
2006;69:229–34.
8.
Riou
B,
Adnet
F,
Baud
F,
et
al.
Guidelines
for
indications
for
the
use
of
extracor-
poreal
life
support
in
refractory
cardiac
arrest.
French
Ministry
of
Health.
Ann
Fr
Anesth
Reanim
2009;28:182–90.
9. Le
Guen
M,
Nicolas-Robin
A,
Carreira
S,
et
al.
Extracorporeal
life
support
follow-
ing
out-of-hospital
refractory
cardiac
arrest.
Crit
Care
2011;15:R29.
10. Kurose
M,
Okamoto
K,
Sato
T,
et
al.
The
determinant
of
severe
cerebral
dysfunc-
tion
in
patients
undergoing
emergency
extracorporeal
life
support
following
cardiopulmonary
resuscitation.
Resuscitation
1995;30:15–20.
11.
Chen
YS,
Chao
A,
Yu
HY,
et
al.
Analysis
and
results
of
prolonged
resuscitation
in
cardiac
arrest
patients
rescued
by
extracorporeal
membrane
oxygenation.
J
Am
Coll
Cardiol
2003;41:197–203.
12.
Massetti
M,
Tasle
M,
Le
Page
O,
et
al.
Back
from
irreversibility:
extracorpo-
real
life
support
for
prolonged
cardiac
arrest.
Ann
Thorac
Surg
2005;79:178–
83.
13.
Sung
K,
Lee
YT,
Park
PW,
et
al.
Improved
survival
after
cardiac
arrest
using
emer-
gent
autopriming
percutaneous
cardiopulmonary
support.
Ann
Thorac
Surg
2006;82:651–6.
14.
Chen
YS,
Lin
JW,
Yu
HY,
et
al.
Cardiopulmonary
resuscitation
with
assisted
extra-
corporeal
life-support
versus
conventional
cardiopulmonary
resuscitation
in
adults
with
in-hospital
cardiac
arrest:
an
observational
study
and
propensity
analysis.
Lancet
2008;372:554–61.
15. Shin
TG,
Choi
JH,
Jo
IJ,
et
al.
Extracorporeal
cardiopulmonary
resuscitation
in
patients
with
inhospital
cardiac
arrest:
a
comparison
with
conventional
car-
diopulmonary
resuscitation.
Crit
Care
Med
2011;39:1–7.
16.
Mégarbane
B,
Leprince
P,
Deye
N,
et
al.
Emergency
feasibility
in
medical
intensive
care
unit
of
extracorporeal
life
support
for
refractory
cardiac
arrest.
Intensive
Care
Med
2007;33:758–64.
17. Safar
P,
Khachaturian
Z,
Klain
M,
et
al.
Recommendations
for
future
research
on
the
reversibility
of
clinical
death.
Crit
Care
Med
1988;16:1077–84.
18. Angelos
M,
Safar
P,
Reich
H.
External
cardiopulmonary
resuscitation
pre-
serves
brain
viability
after
prolonged
cardiac
arrest
in
dogs.
Am
J
Emerg
Med
1991;9:436–43.
19.
Gariboldi
V,
Grisoli
D,
Tarmiz
A,
et
al.
Mobile
extracorporeal
membrane
oxy-
genation
unit
expands
cardiac
assist
surgical
programs.
Ann
Thorac
Surg
2010;90:1548–52.
20.
Vivien
B,
Deye
N,
Mégarbane
B,
et
al.
Extracorporeal
life
support
in
a
case
of
fatal
flecainide
and
betaxolol
poisoning
allowing
successful
cardiac
allograft.
Ann
Emerg
Med
2010;56:409–12.
... nonetheless, several studies have found that strenuous physical activity, such as long-distance running, can lead to serious medical complications. 2 previous reports documented that the risk of sudden cardiac death (Scd) associated with marathon racing in athletes over 35 years of age is between 1/15,000 and 1/220,000. [2][3][4][5] pre-participation cardiovascular screening of competitive athletes has been demonstrated to be beneficial in detecting potentially lethal cardiovascular diseases. 3,6 in addition, the drop in mortality and morbidity among runners having cardiac arrest during races can be attributed to the increased availability of defibrillators on many courses. ...
... [2][3][4][5] pre-participation cardiovascular screening of competitive athletes has been demonstrated to be beneficial in detecting potentially lethal cardiovascular diseases. 3,6 in addition, the drop in mortality and morbidity among runners having cardiac arrest during races can be attributed to the increased availability of defibrillators on many courses. 5,6 according to a recent review by Vancini et al., Basic life Support (BlS) training for health professionals and laypeople can reduce the unfavorable outcomes of resuscitation in athletes. ...
Article
Full-text available
Background: Out-of-hospital cardiac arrest (OHCA) is not common but associated with a low survival rate. There is no evidence investigating the effects of previous Basic Life Support (BLS) training among long-distance runners. The goal of this study is to demonstrate the health characteristics, knowledge, and attitudes towards BLS among marathon runners. Methods: An online cross-sectional survey was asked to all 2019 Chiang Mai University marathon participants as a part of the running registration. Details of health characteristic, running history, and BLS training details were requested. The primary outcomes were knowledge and attitude towards BLS among marathon runners. Results: Of all 10,507 questionnaires sent, the response rate was 92.9%. One-nineth of participants were 50 years of age or above. The mean age was 36.8±9.9 years. Most were male (56.1%) and Thai (99.4%). Only a quarter (2,454 out of 9,761 runners) of study population had previous BLS training. Family history of sudden cardiac death or cardiac death with unknown causes was more in participants with previous BLS training than those without (1.1% vs 0.6%, p = 0.01). Previous BLS training group answered the national emergency call number correctly more than those without (90.4% vs 73.0%, p < 0.001) and previous BLS training group were more likely to initiate CPR than those without (median self-confidence 8 vs 5, respectively, p < 0.001). Conclusions: Only a quarter of running participants have participated in BLS training before entering a marathon running. Having previous BLS training is associated with higher self-confidence to attempt CPR. Organized planning including trained medical staff, adequate equipment, and qualified bystanders is recommended.
... While standard ALS is now a minimum requirement of care, some marathon teams are also providing on-site extracorporeal life support (ECLS) in case of refractory cardiac arrest. 8 The patient was unconscious, and had a gasping breathing, but presented with a strong central and peripheral pulse, which was confirmed by a high blood pressure at monitoring. Internal body temperature was immediately measured to guide on the presence of temperature disturbances especially exertional heat stroke. ...
... For example, a vehicle-based and helicopter-borne ECPR program were introduced in the Paris area with an average low-flow time of 57 minutes and 110 minutes, respectively (31,32). Additionally, multiple case reports and series on pre-hospital ECPR have been published (33)(34)(35) in addition to several forthcoming (pre-hospital) ECPR trials (36-38). ...
Article
Full-text available
Introduction To the best of our knowledge, this is the first case report which provides insights into patient-specific hemodynamics during veno-arterio-venous-extracorporeal membrane oxygenation (VAV ECMO) combined with a left-ventricular (LV) Impella ® micro-axial pump for therapy-refractory cardiac arrest due to acute myocardial infarction, complicated by acute lung injury (ALI). Patient presentation A 54-year-old male patient presented with ST-segment elevation acute coronary syndrome complicated by out-of-hospital cardiac arrest with ventricular fibrillation upon arrival of the emergency medical service. As cardiac arrest was refractory to advanced cardiac life support, the patient was transferred to the Cardiac Arrest Center for immediate initiation of extracorporeal cardiopulmonary resuscitation (ECPR) with peripheral VA ECMO and emergency percutaneous coronary intervention using drug eluting stents in the right coronary artery. Due to LV distension and persistent asystole after coronary revascularization, an Impella ® pump was inserted for LV unloading and additional hemodynamic support (i.e., “ECMELLA”). Despite successful unloading by ECMELLA, post-cardiac arrest treatment was further complicated by sudden differential hypoxemia of the upper body. This so called “Harlequin phenomenon” was explained by a new onset of ALI, necessitating escalation of VA ECMO to VAV ECMO, while maintaining Impella ® support. Comprehensive monitoring as derived from the Impella ® console allowed to illustrate patient-specific hemodynamics of cardiac unloading. Ultimately, the patient recovered and was discharged from the hospital 28 days after admission. 12 months after the index event the patient was enrolled in the ECPR Outpatient Care Program which revealed good recovery of neurologic functions while physical exercise capacities were impaired. Conclusion A combined mechanical circulatory support strategy may successfully be deployed in complex cases of severe cardio-circulatory and respiratory failure as occasionally encountered in clinical practice. While appreciating potential clinical benefits, it seems of utmost importance to closely monitor the physiological effects and related complications of such a multimodal approach to reach the most favorable outcome as illustrated in this case.
... Moreover, sudden deaths in athletes have been reported to be often refractory cardiac arrest (CA), non-responding to traditional advanced cardiovascular life support (ACLS) manoeuvres. [11][12][13] Therefore, there is rising interest in the application of extracorporeal life support (ECLS) that could offer improved outcomes in case of OHCA refractory to standard resuscitation protocols. We turned this interest into a real model, creating a multidisciplinary ECLS team for OHCA during the Volleyball Men's World Championship Final Six, 2018, organised in Turin, Italy. ...
Article
The high incidence of out-of-hospital cardiac arrest refractory to standard resuscitation protocols, despite precompetitive screening, demonstrated the need for a prehospital team to provide an effective system for life support and resuscitation at the Volleyball Men’s World Championship. The evolution of mechanical circulatory support suggests that current advanced cardiovascular life support protocols no longer represent the highest standard of care at competitive sporting events with large spectator numbers. Extracorporeal life support (ECLS) improves resuscitation strategies and offers a rescue therapy for refractory cardiac arrest that can no longer be ignored. We present our operational experience of an out-of-hospital ECLS cardiopulmonary resuscitation team at an international sporting event.
Chapter
Although Acute Limb Ischemia (ALI) is a relatively common complication in patients supported with peripheral veno-arterial extracorporeal membrane oxygenation (vaECMO), it continues to pose a significant challenge, which can lead to major amputations and increased mortality rates. In this chapter, the pathophysiologic mechanisms and the risk factors for peripheral vaECMO-associated ALI are discussed, whereas clinical assessment and diagnostic strategies are presented. Furthermore, an extensive review of the currently suggested preventive measures and their efficacy is provided. Finally, the currently available operative and endovascular revascularization techniques of a viable, acutely ischemic limb are highlighted.
Chapter
The use of veno-arterial extracorporeal membrane oxygenation (ECMO) as circulatory support had been stepwise implemented from in-hospital intensive care units over catheterization laboratories or emergency departments to out-of-hospital scenarios in the treatment of cardiac arrest. This transferability and usability of ECMO were expected to improve the poor outcome of patients with out-of-hospital cardiac arrest (OHCA), as ECMO might work as extracorporeal life support (ECLS) in refractory cardiac arrest. Low-flow status from conventional cardiopulmonary resuscitation (CPR) should be as short as possible to improve overall and neurological prognosis, hence one implemented the concept of “mobile ECMO.” The decision-making on early in-hospital or in-field ECLS implantation depends on various factors including infrastructure, logistic conditions, patient-related characteristics, and deployment strategy of ECLS team. The current evidence on ECLS therapy in patients with OHCA demonstrated inconsistent results. The ARREST trial indicated potential use of early in-hospital ECLS in patients with OHCA and refractory ventricular dysrhythmia, however, long-term follow-up comparing ECLS and standard care was not applicable. The PRAGUE OHCA and EROCA trials each detected no benefit of in-hospital ECLS implantation versus conventional cardiopulmonary resuscitation (CPR) in patients with shockable and non-shockable rhythm, overall. A final conclusion on early in-hospital ECLS therapy was therefore not applicable. Pre-hospital ECLS implantation was solely successfully performed in selected cases and in highly selected areas with specialized set-up and teams. As in-field ECLS implantation has not been investigated in randomized or even controlled trials yet, it remains an individual therapy attempt in specific emergency medical systems. The currently active APACAR2 trial will address the use of pre-hospital ECLS implantation specifically and might contribute to future direction in ECLS therapy in OHCA patients.
Article
Full-text available
Aim: Cardiogenic shock (CS) is a hemodynamically complex multisystem syndrome associated with persistently high morbidity and mortality. As CS is characterized by progressive failure to provide adequate systemic perfusion, supporting end-organ perfusion using mechanical circulatory support (MCS) seems intriguing. Since most patients with CS present in the catheterization laboratory, percutaneously implantable systems have the widest adoption in the field. We evaluated feasibility, outcomes, and complications after the introduction of a full-percutaneous program for both the Impella CP device and venoarterial extracorporeal membrane oxygenator (VA-ECMO). Methods: PREPARE CardShock (PRospective REgistry of PAtients in REfractory cardiogenic shock) is a prospective single-center registry, including 248 consecutive patients between May 2019 and April 2021, who underwent cardiac catheterization and displayed advanced cardiogenic shock. The median age was 70 (58-77) years and 28% were female. Sixty-five percent of the cases had cardiac arrest, of which 66% were out-of-hospital cardiac arrest. A local standard operating procedure (SOP) indicating indications as well as relative and absolute contraindications for different means of MCS (Impella CP or VA-ECMO) was used to guide MCS use. The primary endpoint was in-hospital death and secondary endpoints were spontaneous myocardial infarction and major bleedings during the hospital stay. Results: Overall mortality was 50.4% with a median survival of 2 (0-6) days. Significant independent predictors of mortality were cardiac arrest during the index event (odds ratio [OR] with 95% confidence interval [CI]: 2.53 [1.43-4.51]; p = 0.001), age > 65 years (OR: 2.05 [1.03-4.09]; p = 0.036]), pH < 7.30 (OR: 2.69 [1.56-4.66]; p < 0.001), and lactate levels > 2 mmol/L (OR: 4.51 [2.37-8.65]; p < 0.001). Conclusions: Conclusive SOPs assist target-orientated MCS use in CS. This study provides guidance on the implementation, validation, and modification of newly established MCS programs to aid centers that are establishing such programs.
Article
Full-text available
Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been used as extracorporeal cardiopulmonary resuscitation (ECPR) to support further resuscitation efforts in patients with cardiac arrest, yet its clinical effectiveness remains uncertain. Objectives: This study reviews the role of ECPR in contemporary resuscitation care compared to no ECPR and/or standard care, e.g. conventional CPR, and quantitatively summarize the rates of long-term neurologically intact survival after adult in-hospital cardiac arrest (IHCA) or out-of-hospital cardiac arrest (OHCA). Methods: We searched the following databases on January 31 st, 2020: CENTRAL, MEDLINE, Embase, and Web of Science. We followed PRISMA guidelines and used PICO format to summarize the research questions. Risk of bias was assessed using the ROBINS-I tool. Pooled risk ratios (RRs) for each outcome of interest were calculated. Quality of evidence was evaluated according to GRADE guidelines. Results: Six cohort studies were included, totaling 1750 patients. Of these, 530 (30.3%) received the intervention, and 91 (17.2%) survived with long-term neurologically intact survival. ECPR compared to no ECPR is likely associated with improved long-term neurologically intact survival after cardiac arrest in any setting (risk ratio [RR] 3.11, 95% confidence interval [CI] 2.06-4.69; p < 0.00001) (GRADE: Very low quality). Similar results were found for long-term neurologically intact survival after IHCA (RR 3.21, 95% CI 1.74-5.94; p < 0.0002) (GRADE: Very low quality) and OHCA (RR 3.11, 95% CI 1.50-6.47; p < 0.002) (GRADE: Very low quality). Long-term time frames for neurologically intact survival (three months to two years) were combined into a single category, defined a priori as a Glasgow-Pittsburgh cerebral performance category (CPC) of 1 or 2. Conclusions: VA-ECMO used as ECPR is likely associated with improved long-term neurologically intact survival after cardiac arrest. Future evidence from randomized trials is very likely to have an important impact on the estimated effect of this intervention and will further define optimal clinical practice. Review registration: PROSPERO CRD42020171945.
Article
Objectives: This systematic review aims to summarize the body of available literature on pediatric extracorporeal cardiopulmonary resuscitation in order to delineate current utilization, practices, and outcomes, while highlighting gaps in current knowledge. Data sources: PubMed, Embase, Scopus, Cochrane Library, and ClinicalTrials.gov databases. Study selection: We searched for peer-reviewed original research publications on pediatric extracorporeal cardiopulmonary resuscitation (patients < 18 yr old) and were inclusive of all publication years. Data extraction: Our systematic review used the structured Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. Our initial literature search was performed on February 11, 2019, with an updated search performed on August 28, 2019. Three physician reviewers independently assessed the retrieved studies to determine inclusion in the systematic review synthesis. Using selected search terms, a total of 4,095 publications were retrieved, of which 96 were included in the final synthesis. Risk of bias in included studies was assessed using the Risk of Bias in Non-Randomized Studies of Interventions-I tool. Data synthesis: There were no randomized controlled trials of extracorporeal cardiopulmonary resuscitation use in pediatrics. A vast majority of pediatric extracorporeal cardiopulmonary resuscitation publications were single-center retrospective studies reporting outcomes after in-hospital cardiac arrest. Most pediatric extracorporeal cardiopulmonary resuscitation use in published literature is in cardiac patients. Survival to hospital discharge after extracorporeal cardiopulmonary resuscitation for pediatric in-hospital cardiac arrest ranged from 8% to 80% in included studies, and there was an association with improved outcomes in cardiac patients. Thirty-one studies reported neurologic outcomes after extracorporeal cardiopulmonary resuscitation, of which only six were prospective follow-up studies. We summarize the available literature on: determination of candidacy, timing of activation of extracorporeal cardiopulmonary resuscitation, staffing/logistics, cannulation strategies, outcomes, and the use of simulation for training. Conclusions: This review highlights gaps in our understanding of best practices for pediatric extracorporeal cardiopulmonary resuscitation. We summarize current studies available and provide a framework for the development of future studies.
Article
Full-text available
Extracorporeal life support (ECLS) has recently shown encouraging results in the resuscitation of in-hospital (IH) refractory cardiac arrest. We assessed the use of ECLS following out-of-hospital (OH) refractory cardiac arrest. We evaluated 51 consecutive patients who experienced witnessed OH refractory cardiac arrest and received automated chest compression and ECLS upon arrival in the hospital. Patients with preexisting severe hypothermia who experienced IH cardiac arrest were excluded. A femorofemoral ECLS was set up on admission to the hospital by a mobile cardiothoracic surgical team. Fifty-one patients were included (mean age, 42 ± 15 years). The median delays from cardiac arrest to cardiopulmonary resuscitation and ECLS were, respectively, 3 minutes (25th to 75th interquartile range, 1 to 7) and 120 minutes (25th to 75th interquartile range, 102-149). Initial rhythm was ventricular fibrillation in 32 patients (63%), asystole in 15 patients (29%) patients and pulseless rhythm in 4 patients (8%). ECLS failed in 9 patients (18%). Only two patients (4%) (95% confidence interval, 1% to 13%) were alive at day 28 with a favourable neurological outcome. There was a significant correlation (r = 0.36, P = 0.01) between blood lactate and delay between cardiac arrest and onset of ECLS, but not with arterial pH or blood potassium level. Deaths were the consequence of multiorgan failure (n = 43; 47%), brain death (n = 10; 20%) and refractory hemorrhagic shock (n = 7; 14%), and most patients (n = 46; 90%) died within 48 hours. This poor outcome suggests that the use of ECLS should be more restricted following OH refractory cardiac arrest.
Article
Full-text available
In 1982 a nationwide program of pre-participation screening including 12-lead electrocardiography (ECG) was launched in Italy. The aim of this article is to examine whether this 25-year screening program should be considered a valid and advisable public health strategy. The analysis of data coming from the long-running Italian experience indicates that ECG screening has provided adequate sensitivity and specificity for detection of potentially lethal cardiomyopathy or arrhythmias and has led to substantial reduction of mortality of young competitive athletes by approximately 90%. Screening was feasible thanks to the Italian Health System, which is developed in terms of health care and prevention services, and because of the limited costs of cardiovascular evaluation in the setting of a mass program. On the basis of current scientific evidence the implementation of a mass-screening program aimed to prevent athletic-field sudden cardiac death should be at least carefully considered by public health administrators worldwide.
Article
Data from the London Marathon, with 650 000 completed runs, show that cardiac arrests occur even in the most experienced runners. Although coronary artery disease was the commonest cause of sudden cardiac arrest (SCA) with five deaths and six resuscitations, hypertrophic cardiomyopathy or idiopathic left ventricular hypertrophy (HCM) was diagnosed at autopsy on three occasions. HCM deaths had the same average age as the runners with ischaemic heart disease who had SCA or sudden cardiac death. The cardiac arrests were at the finish in less than one-third of cases and the remainder occurred between 6 and 26 miles on the course. Only one of the eight runners who died had reported symptoms to his family or physician suggestive of cardiac disease. The runner who had reported pre-race angina pain was investigated with a negative exercise stress test prior to the marathon and despite this died with a left anterior descending coronary artery stenosis. The cardiac death rate for the London Marathon is 1 in 80 000 finishers.
Article
We investigated whether the survival of patients with inhospital cardiac arrest could be extended by extracorporeal cardiopulmonary resuscitation supported with extracorporeal membrane oxygenation compared with those of conventional cardiopulmonary resuscitation. : A retrospective, single-center, observational study. A tertiary care university hospital. We retrospectively analyzed a total of 406 adult patients with witnessed inhospital cardiac arrest receiving cardiopulmonary resuscitation for >10 mins from January 2003 to June 2009 (85 in the extracorporeal cardiopulmonary resuscitation group and 321 in the conventional cardiopulmonary resuscitation group). None. The primary end point was a survival discharge with minimal neurologic impairment. Propensity score matching was used to balance the baseline characteristics and cardiopulmonary resuscitation variables that could potentially affect prognosis. In the matched population (n = 120), the survival discharge rate with minimal neurologic impairment in the extracorporeal cardiopulmonary resuscitation group was significantly higher than that in the conventional cardiopulmonary resuscitation group (odds ratio of mortality or significant neurologic deficit, 0.17; 95% confidence interval, 0.04-0.68; p = .012). In addition, there was a significant difference in the 6-month survival rates with minimal neurologic impairment (hazard ratio, 0.48; 95% confidence interval, 0.29-0.77; p = .003; p <.001 by stratified log-rank test). In the subgroup based on cardiac origin, extracorporeal cardiopulmonary resuscitation also showed benefits for survival discharge (odds ratio, 0.19; 95% confidence interval, 0.04-0.82; p = .026) and 6-month survival with minimal neurologic impairment (hazard ratio, 0.56; 95% confidence interval, 0.33-0.97; p = .038; p = .013 by stratified log-rank test). Extracorporeal cardiopulmonary resuscitation showed a survival benefit over conventional cardiopulmonary resuscitation in patients who received cardiopulmonary resuscitation for >10 mins after witnessed inhospital arrest, especially in cases with cardiac origins.
Article
Extracorporeal membrane oxygenation (ECMO) is an effective technique to provide emergency mechanical circulatory or respiratory assistance in critically ill patients. A Mobile Remote Cardiac Assist unit was created to implant ECMO in patients from outside our institution and bring them back in our intensive care unit for follow-up when stabilized. This study was undertaken to evaluate the feasibility and the preliminary results of this procedure. Between March 2006 and June 2008, 38 consecutive patients with acute cardiac or respiratory failure were implanted with percutaneous ECMO. The logistic concerns, indications, complications, and outcomes of these patients were analyzed. There were no logistic or technical problems during the round trip or ECMO implantation. Mean distance from our intensive care unit was 68 km (1 to 230). Maximal time limit between the phone call and implantation was 90 minutes. The indications were fulminant myocarditis, pharmacologic suicide attempt, acute myocardial infarction, postpartum cardiopathy, end-stage cardiomyopathy, with left ventricular ejection fraction of 0.19 ± 0.05 (n = 32), or acute respiratory distress syndrome without cardiac failure (n = 6). Patients received a percutaneous venoarterial femoral ECMO with immediate reperfusion of the limb or venovenous ECMO for isolated lung failure. Seventeen patients (45%) were successfully weaned from ECMO after 9.4 ± 8.7 days. Four patients (11%) were transplanted. One patient was switched to a left ventricular assist device and was then successfully transplanted. Twenty-one patients (55%) survived to hospital discharge. The Mobile Cardiac Assist unit allowed emergency implantation of ECMO support in remote institutions without any logistic or technical problems.
Article
Use of cardiac allograft for transplantation from donors after acute poisoning is a matter of debate because of potential toxic organ injuries, especially if death results from massive ingestion of cardiotoxic drugs. We report successful allograft cardiac transplantation from a brain-dead patient after severe flecainide and betaxolol self-poisoning requiring extracorporeal life support. Extracorporeal life support was initiated in the emergency department because of a refractory cardiac arrest caused by the cardiotoxicants' ingestion and continued after the onset of brain death to facilitate organ donation of the heart, liver, and kidneys. Forty-five months later, each organ recipient was alive, with normal graft function.
Article
Published data on the use of extracorporeal membrane oxygenation (ECMO) as a supportive measure during or immediately after cardiopulmonary resuscitation (CPR) in adults (older than 18 years) shows mixed results. To assess the clinical outcomes of the use of ECMO in this modality and to look for predictors of mortality, we performed a meta-analysis (MA) of individual patients collected from observational studies. An electronic PubMed search restricted to English-language publications between 1990 and 2007, using a consensus restrictive criterion, retrieved 141 titles. After full text evaluation, 11 clinical series and nine case reports were considered appropriate and included in our MA. Data on 135 individually identified adult patients (male:female = 1.6:1) were collected. Median age for the group was 56 years (range 18-83), and the median ECMO run was 54 hours (range 0-3881). Overall survival to hospital discharge was 40% (54 of 135). The most common diagnosis leading to cardiac arrest was acute myocardial infarction (46 of 135 patients). Compared with the youngest group (17-41 years), odds ratio (OR) for mortality was higher for age group 41-56 years (OR 2.9 95%; CL, 1.6-8.2) and those older than 67 years (OR 3.4%; 95% CL, 1.2-9.7). Duration of ECMO support measured in days was also a predictor of mortality, with significant better outcome for those supported between 0.875 and 2.3 days (OR 0.2; 95% CL, 0.07-0.6). There was a negative trend in survival when manual CPR lasted >30 minutes without prompt ECMO initiation (OR 1.9; 95% CL, 0.9-4.2). This work confirms the expectations for a better survival when E-CPR is used in younger patients, for shorter periods of time and after expeditious implementation during or immediately after manual CPR. Neurologic sequelae and other major complications, although suspected to be high, are poorly described in the reviewed literature.